Publication | Open Access
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial
21
Citations
16
References
2023
Year
ClinicalTrials.gov: NCT04913675.
| Year | Citations | |
|---|---|---|
Page 1
Page 1